Allergen‐specific immunotherapy with a monophosphoryl lipid A‐adjuvanted vaccine: reduced seasonally boosted immunoglobulin E production and inhibition of basophil histamine release by therapy‐induced blocking antibodies
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Summary: Background Allergen‐specific immunotherapy represents a causal form of treatment for IgE‐mediated allergies. The allergen extract‐based analyses of immunotherapy‐induced effects yielded highly controversial results regarding a beneficial role of therapy‐induced IgG antibodies. Objective We analysed allergen‐specific IgE, IgG subclass, and IgM responses in patients treated with a grass pollen allergy vaccine adjuvanted with monophosphoryl lipid A (MPL), a Th1‐inducing agent, and in a placebo group using recombinant timothy grass pollen allergen molecules (rPhl p 1, rPhl p 2, rPhl p 5). Results The strong induction of allergen‐specific IgG 1 and IgG 4 antibodies observed only in the actively treated group was associated with significant clinical improvement. Therapy‐induced allergen‐specific IgM and IgG 2 responses were also noted in several actively treated patients. An inhibition of allergen‐dependent basophil histamine release was only obtained with sera containing therapy‐induced allergen‐specific IgG, but not with sera obtained before therapy or from placebo‐treated patients. Moreover, patients with therapy‐induced allergen‐specific IgG antibodies showed a reduced induction of allergen‐specific IgE responses during seasonal grass pollen exposure. Conclusion Successful immunotherapy with the MPL‐adjuvanted grass pollen allergy vaccine is associated with the production of allergen‐specific IgG antibodies. These blocking antibodies may have protective effects by inhibiting immediate‐type reactions and systemic increases of IgE responses caused by seasonal allergen exposure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Allergen immunotherapy: Therapeutic vaccines for allergic diseases A WHO position paper
Bousquet, J., Lockey, R., & Malling, H.-J. (1998) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(98)70271-4 · Cited by 1,581
PROPHYLACTIC INOCULATION AGAINST HAY FEVER
Noon, L. (1911) · The Lancet · doi:10.1016/s0140-6736(00)78276-6 · Cited by 1,351
Romagnani, S. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)80019-9 · Cited by 1,078
van Neerven, R. J. J., Wikborg, T., Lund, G., Jacobsen, B., Brinch-Nielsen, A., Arnved, J., & Ipsen, H. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.5.2944 · Cited by 384
Immunologic changes associated with allergen immunotherapy
Durham, S. R., & Till, S. J. (1998) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(98)70079-x · Cited by 338
The future of antigen-specific immunotherapy of allergy
Valenta, R. (2002) · Nature Reviews Immunology · doi:10.1038/nri824 · Cited by 314
Self-citationMonophosphoryl lipid A as an adjuvant. Past experiences and new directions.
Ulrich, J. T., & Myers, K. R. (1995) · PubMed · Cited by 301
Drachenberg, K. J., Wheeler, A. W., Stuebner, P., & Horak, F. (2001) · Allergy · doi:10.1034/j.1398-9995.2001.056006498.x · Cited by 285
Self-citationHsu, C.-H., Chua, K.-Y., Tao, M.-H., Lai, Y.-L., Wu, H.-D., Huang, S.-K., & Hsieh, K.-H. (1996) · Nature Medicine · doi:10.1038/nm0596-540 · Cited by 285
Kawano, Y., Noma, T., & Yata, J. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.11.4948 · Cited by 233
Monophosphoryl Lipid A as an Adjuvant: Past Experiences and New Directions
Ulrich, J. T., & Myers, K. R. (1995) · Pharmaceutical Biotechnology · doi:10.1007/978-1-4615-1823-5_21 · Cited by 222
Interleukin 3 activates human blood basophils via high-affinity binding sites.
Valent, P., Besemer, J., Muhm, M., Majdic, O., Lechner, K., & Bettelheim, P. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.14.5542 · Cited by 204
Self-citationSafety and immunogenicity of a hepatitis B vaccine formulated with a novel adjuvant system
Thoelen, S., Damme, P. V., Matheï, C., Leroux-Roels, G. G., Desombere, I., Safary, A., Vandepapelière, P., Slaoui, M., & Meheus, A. (1998) · Vaccine · doi:10.1016/s0264-410x(97)00254-5 · Cited by 156
Vrtala, S., Sperr, W. R., Reimitzer, I., van Ree, R., Laffer, S., Müller, W., Valent, P., Lechner, K., Rumpold, H., Kraft, D., et al. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.9.4773 · Cited by 142
Self-citationWheeler, A. W., Marshall, J. S., & Ulrich, J. T. (2001) · International Archives of Allergy and Immunology · doi:10.1159/000049504 · Cited by 115
Vrtala, S., Ball, T., Spitzauer, S., Pandjaitan, B., Suphioglu, C., Knox, B., Sperr, W. R., Valent, P., Kraft, D., & Valenta, R. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.12.6137 · Cited by 109
Self-citationVrtala, S., Susani, M., Sperr, W. R., Valent, P., Laffer, S., Dolecek, C., Kraft, D., & Valenta, R. (1996) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(96)80156-4 · Cited by 102
Self-citationHigh IgG4 antibody level is associated with failure of immunotherapy with inhalant allergens
Djurup, R., & Malling, H. ‐. (1987) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.1987.tb02040.x · Cited by 102
Laffer, S., Spitzauer, S., Susani, M., PAIRLEITNERA, H., Schweiger, C., Grönlund, H., Menz, G., Pauli, G., Ishii, T., Nolte, H., et al. (1996) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(96)70099-4 · Cited by 91
Self-citationBall, T., Fuchs, T., Sperr, W. R., Valent, P., Vangelista, L., Kraft, D., & Valenta, R. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.11.1277 · Cited by 80
Self-citationFlicker, S., Vrtala, S., Steinberger, P., Vangelista, L., Bufe, A., Petersen, A., Ghannadan, M., Sperr, W. R., Valent, P., Norderhaug, L., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.7.3849 · Cited by 75
Self-citationMaximal rise in IgE antibody following ragweed pollination season
Henderson, L. L., Larson, J. B., & Gleich, G. J. (1975) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(75)80003-0 · Cited by 70
Denépoux, S., Eibensteiner, P., Steinberger, P., Vrtala, S., Visco, V., Weyer, A., Kraft, D., Banchereau, J., Valenta, R., & Lebecque, S. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01703-2 · Cited by 62
Self-citationImmunostimulatory DNA and applications to allergic disease☆☆☆★
Uden, J. H. V., & Raz, E. (1999) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(99)70066-7 · Cited by 60
Immunological Mechanisms Operative in Allergen–Specific Immunotherapy
Ebner, C. (1999) · International Archives of Allergy and Immunology · doi:10.1159/000024168 · Cited by 37
Tippett, J. (1999) · Radiologic Clinics of North America · doi:10.1016/s0033-8389(22)00162-2 · Cited by 31
Allergenic Activity of a Major Grass Pollen Allergen Is Elevated in the Presence of Nasal Secretion
Bufe, A., Gehlhar, K., Schramm, G., Schlaak, M. S., & Becker, W. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.4.9709040 · Cited by 29
Sehra, Chugh, & Gangal (1998) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.1998.00448.x · Cited by 19
Clinton, P. M., Kemeny, D. M., Youlten, L. J. F., & Lessof, M. H. (2009) · International Archives of Allergy and Applied Immunology · doi:10.1159/000234921 · Cited by 18
Cited by
Immunological mechanisms of allergen-specific immunotherapy
Larché, M., Akdis, C. A., & Valenta, R. (2006) · Nature Reviews Immunology · doi:10.1038/nri1934 · Cited by 849
Self-citationVaccination with genetically engineered allergens prevents progression of allergic disease
Niederberger, V., Horak, F., Vrtala, S., Spitzauer, S., Krauth, M.-T., Valent, P., Reisinger, J., Pelzmann, M., Hayek, B., Kronqvist, M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404735101 · Cited by 376
Self-citationThe role of allergen‐specific IgE, IgG and IgA in allergic disease
Shamji, M. H., Valenta, R., Jardetzky, T., Verhasselt, V., Durham, S. R., Würtzen, P. A., & van Neerven, R. J. J. (2021) · Allergy · doi:10.1111/all.14908 · Cited by 336
Self-citationFrancis, J. N., James, L. K., Paraskevopoulos, G., Wong, C., Calderon, M. A., Durham, S. R., & Till, S. J. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.01.072 · Cited by 329
Akdis (2020) · doi:10.1111/pai.13189 · Cited by 320
Metadata
- Authors
- Mothes, N., Heinzkill, M., Drachenberg, K. J., Sperr, W. R., Krauth, M. T., Majlesi, Y., Semper, H., Valent, P., Niederberger, V., Kraft, D., & Valenta, R.
- Venue
- Clinical & Experimental Allergy
- Publisher
- Wiley
- Published
- 2003-09
- Volume
- 33
- Issue
- 9
- Pages
- 1198-1208
- ISSN
- 0954-7894 (ISSN-L)
- 1365-2222
- OpenAlex
- W1990702493
- Cited by
- 269
- References
- 29
- FWCI
- 9.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.